In HER2+ breast cancer, Grb7 is co-overexpressed with HER2, leading to enhanced tumorigenesis and cell proliferation (Bai and Luoh, 2007; Chu et al., 2010; Pradip et al., 2013). Here, ERBB2 is linked to breast carcinoma.